The Prevalence and Awareness of Cardiometabolic Risk Factors in Southern Chinese Population with Coronary Artery Disease
Table 1
Patients demographic stratified by gender.
Variable
Total ()
Male ()
Female ()
Age (years)
63.7 ± 11.4
62.0 ± 0.3
67.3 ± 0.4
<0.001
Body mass index (kg/m2)
23.9 ± 3.3
23.8 ± 0.1
24.1 ± 0.1
0.129
Systolic blood pressure (mmHg)
132 ± 23
131 ± 1
134 ± 1
0.001
Diastolic blood pressure (mmHg)
77 ± 13
77 ± 1
77 ± 1
0.694
Total cholesterol (mmol/L)
4.63 ± 1.12
4.48 ± 0.03
4.94 ± 0.04
<0.001
Low-density lipoprotein cholesterol (mmol/L)
2.91 ± 1.25
2.84 ± 0.03
3.06 ± 0.05
<0.001
High-density lipoprotein cholesterol (mmol/L)
1.06 ± 0.29
1.01 ± 0.01
1.16 ± 0.01
<0.001
Triglycerides (mmol/L)
1.81 ± 1.31
1.76 ± 0.03
1.91 ± 0.05
0.009
Lysophosphatidic acid (g/L)
0.36 (0.22, 0.76)
0.38 (0.22, 0.77)
0.35 (0.22, 0.71)
0.149
Apolipoprotein A (g/L)
1.10 ± 0.28
1.05 ± 0.01
1.19 ± 0.01
<0.001
Apolipoprotein B (g/L)
0.78 ± 0.28
0.76 ± 0.01
0.83 ± 0.01
<0.001
Fasting glucose (mmol/L)
6.38 ± 2.62
6.26 ± 0.07
6.63 ± 0.10
0.002
Uric acid (umol/L)
376 ± 113
390 ± 3
348 ± 4
<0.001
Duration of coronary artery disease (years)
First diagnosed patients ()
—
—
—
History diagnosed patients ()
3.00 (1.00, 8.00)
2.29 (0.91, 6.66)
4.45 (1.12, 10.0)
<0.001
Marriage (%)
89.9
93.8
81.6
<0.001
Years of education (%)
<0.001
≤9
61.4
57.2
69.6
10–12
20.0
21.8
16.8
≥13
18.6
21.0
13.6
Physical activities (%)
0.101
None
35.9
38.1
31.4
≤30 min
20.9
20.1
22.6
>30 min
43.2
41.8
46.0
Smoking (%)
<0.001
Never
59.0
41.3
95.4
Past
8.0
10.9
2.0
Current
32.9
47.7
2.6
Alcohol drinking (%)
<0.001
Never
77.9
67.6
98.2
Past
6.9
10.2
0.4
Current
15.2
22.2
1.4
Type of coronary artery disease (%)
<0.001
Stable status
41.0
36.5
50.2
Unstable angina pectoris
35.1
30.4
36.1
Myocardial infarction
23.9
33.1
13.7
Coronary artery stenosis degree of CAG
<0.001
Not conduct
34.9
28.0
49.0
<50%
12.1
10.7
15.0
50–74.9%
7.9
8.0
7.8
≥75%
45.1
53.3
28.2
Triple vessel disease (%) ( with CAG reports)
51.1
53.5
43.7
<0.001
Treatment of coronary disease (%)
Percutaneous coronary intervention
50.6
59.1
34.2
<0.001
Coronary artery bypass graft
2.3
2.8
1.2
0.018
History of diseases (%)
Hypertension
56.6
52.8
63.9
<0.001
Diabetes mellitus
28.3
25.7
33.6
<0.001
Dyslipidemia
25.1
23.8
27.6
0.046
Current prevalence of diseases (%)
Hypertension (≥140/90 mmHg for SBP/DBP or drug use)
91.3
91.4
91.0
0.747
Diabetes mellitus (≥7.0 mmol/L for FPG or drug use)
40.9
39.6
43.3
0.111
Dyslipidemia*
92.0
93.7
88.9
<0.001
Awareness rate of disease (%)
Hypertension
64.4
60.7
71.7
<0.001
Diabetes mellitus
66.3
63.3
71.6
0.011
Dyslipidemia
28.5
26.6
32.7
0.005
The metabolic syndrome and its individual components (%)
Defined by BMI ≥25 kg/m2
57.9
54.3
65.0
<0.001
Defined by BMI ≥25 kg/m2 ( with waist circumference)
58.5
54.8
67.2
<0.001
Defined by waist circumference ()
66.9
61.2
80.2
<0.001
Obesity (BMI ≥25 kg/m2)
34.1
34.5
33.5
0.647
Obesity (waist circumference >85/80 cm for male/female)
62.5
53.8
83.2
<0.001
Triglycerides (≥1.70 mmol/L)
38.8
36.9
42.5
0.010
High-density lipoprotein cholesterol (<1.0/1.3 mmol/L for male/female)
56.5
50.3
69.1
<0.001
High blood pressure (≥130/85 mmHg for SBP/DBP)
93.7
93.7
93.6
0.922
Fasting plasma glucose (≥5.6 mmol/L)
58.0
56.6
60.9
0.055
Only 1303 but not all study samples measured waist circumference. CAG: coronary angiography.
*Dyslipidemia was defined as any one of triglyceride ≥2.26 mmol/L, total cholesterol ≥6.22 mmol/L, low-density lipoprotein cholesterol ≥4.14 mmol/L, high-density lipoprotein cholesterol <1.04 mmol/L, and/or using cholesterol-lowering medicines during the last 2 weeks.
